Biotech takeover target Abivax sinks over 37% as cancer cases cloud trial data for bowel disease drug

A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

Kategori: Jeopolitik

Haberin tamamını oku →

Gözlem Hattı Ana Sayfa

Hakkımızda | Gizlilik Politikası